Pomerantz LLP Announces New Paris Office
NEW YORK, 2017-04-03 15:00 CEST (GLOBE NEWSWIRE) --
Pomerantz LLP, one of the most respected law firms in the United States dedicated to securities class action litigation, is pleased to announce the opening of an office in Paris.
French lawyer, Nicolas Tatin, will head the Paris office as Pomerantz’s Director-Business Development Consultant for France, Benelux, Monaco and Switzerland. He will advise institutional investors in the European Union on how best to evaluate losses to their investment portfolios attributable to financial misconduct, and how best to maximize their potential recoveries in U.S. and international securities litigations.
Mr. Tatin was previously a financial lawyer at ERAFP, France’s €24bn pension and retirement fund for civil servants, where he provided legal advice on the selection of management companies and the implementation of mandates entrusted to them by ERAFP.
Mr. Tatin began his career at Natixis Asset Management, before joining BNP Paribas Investment Partners, where he developed expertise in the legal structuring of investment funds and acquired a global and cross-functional approach to the asset management industry.
Mr. Tatin graduated in International law and received an MBA from IAE Paris, the Sorbonne Graduate Business School.
Pomerantz’s Managing Partner, Jeremy A. Lieberman, stated, “We are excited to expand our firm’s operations and client development efforts to France and Continental Europe. More than eighty years ago, Abraham Pomerantz founded our firm on the basic principle that every investor—whether a large institutional investor or pensioner saving for his golden years—has a right to his day in court when victimized by securities fraud and corporate theft. It is a tribute to Mr. Pomerantz’s trailblazing spirit that ever so gradually, governments and judicial systems throughout the world are now recognizing this right, and paving the way for class or collective redress in securities fraud lawsuits. Opening an office in France cements Pomerantz’s commitment to serving our European and international clients in litigations occurring both in the United States and international jurisdictions. Mr. Tatin’s experience as a lawyer at one of France’s largest public pension funds, as well as at one of its largest asset managers, makes him uniquely qualified to advise institutional investors in France and throughout Europe.”
Mr. Tatin commented: "In Europe, Pomerantz has already contributed significantly to the awareness of institutional investors who wish to adopt a proactive approach in the implementation of class action policy and to assert their rights by actively participating in securities litigation. It is with great enthusiasm that I join the Pomerantz team. With the opening of the Paris office, I look forward to furthering Pomerantz's commitment to advising and supporting European institutional investors with my knowledge and experience of local legal practices."
Pomerantz protects, expands, and vindicates shareholder rights through our securities litigation services and portfolio monitoring program. The firm represents some of the largest pension funds, asset managers and institutional investors around the globe, monitoring assets of $3 trillion, and recovering billions of dollars over the years for defrauded investors.
For more information about the firm, visit Pomerantz at:www.pomerantzlawfirm.com.
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Ved at skrive dig op her, vil du modtage pressemeddelelser på mail når de udsendes. Indtast din mail og følg instruktionerne. Det er ligeså let at melde sig fra igen.
Flere pressemeddelelser fra Nasdaq OMX
Kofax, Inc.18.10.2017 08:02 | pressemeddelelse
Kofax Wins "Most Innovative Solution for Banking Customer Authentication" Award for Third Consecutive Year
IASLC18.10.2017 06:26 | pressemeddelelse
World Conference on Lung Cancer Wednesday Press Conference: PD-1/PD-L1 Advancements and Interventions to Prevent and Treat Lung Cancer
Barings17.10.2017 16:31 | pressemeddelelse
Barings Supports New Mountain Capital Investment in DRB Systems
Crown Bioscience Inc.17.10.2017 16:14 | pressemeddelelse
Crown Bioscience to Showcase Scientific Expertise in Preclinical Evaluation of Investigational Cancer Compounds
Oxford Immunotec17.10.2017 15:17 | pressemeddelelse
Oxford Immunotec Schedules Third Quarter 2017 Earnings Release and Conference Call for October 31, 2017
IASLC17.10.2017 08:17 | pressemeddelelse
World Conference on Lung Cancer Tuesday Press Conference: Evidence to Support Innovative Lung Cancer Interventions
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum